Last updated: 12 September 2026 · Content curated by Dr. Shabnam Choudhary · Medically reviewed by Dr. Saffiyyah Chaudhary
Quick Answer
Allogeneic Stem Cell Transplant in India is typically planned at $30,000–$80,000. The stored stay is 6–10 weeks nearby, but the actual episode depends on eligibility, the procedure-specific plan, complications and discharge criteria.
After conditioning, donor peripheral-blood or marrow cells are infused. Immunosuppression supports engraftment and limits graft-versus-host disease while infection surveillance continues. donor work-up precedes conditioning and infusion, followed by several weeks to engraftment and months of close immune and GVHD monitoring. A written estimate should use the exact procedure name and state its clinical assumptions.
- India cost range
- $30,000–$80,000
- Typical starting point
- $30,000
- Typical hospital stay
- 6–10 weeks nearby
- Procedure time
- donor work-up precedes conditioning and infusion, followed by several weeks to engraftment and months of close immune and GVHD monitoring
- Recovery
- Blood-count recovery is only the first milestone. Immune reconstitution, graft-versus-host disease, viral reactivation and immunosuppressant management continue for months.
Major cost factors: donor type and hla work-up, graft source and procurement, conditioning intensity, gvhd prophylaxis and monitoring. International patients should also budget for accommodation, airport transfers, a medical visa, medicines and follow-up.
Often quoted separately: unrelated-donor registry procurement; therapy needed to reach remission; major gvhd or infection treatment; graft failure or second donation; long-term immunosuppression and survivorship.
Why request a cost through GAF rather than a hospital?
Writing to one campus gets you that campus’s package. A GAF request is reviewed against your records and returned as suitable doctor and hospital options with an indicative, itemised estimate. There is no obligation to book.
- Doctor review first. The number follows a reading of your imaging, test results and clinical records, not a brochure range.
- Hospital options. You can compare listed campuses before you travel, instead of starting over with each international desk.
- International-patient coordination. Visa letters, records routing and companion logistics sit with the same request.
An allogeneic stem cell transplant replaces blood formation with stem cells from another person after conditioning and adds a donor immune effect against selected blood cancers or marrow disorders. It may be considered for selected acute leukaemias, myelodysplastic syndromes, marrow-failure disorders and other high-risk haematological diseases after disease, donor and fitness review.
Work-up includes disease genetics and remission status, high-resolution HLA typing, donor health and infectious screening, organ testing, psychosocial and caregiver assessment and a graft-versus-host disease prevention plan. A donor match alone is not an indication. Uncontrolled infection, refractory disease, major organ impairment or lack of safe long-term follow-up can make transplant unsafe or require a different plan.
After conditioning, donor peripheral-blood or marrow cells are infused. Immunosuppression supports engraftment and limits graft-versus-host disease while infection surveillance continues. This is a transplant-unit episode with protective precautions and rapid ICU, blood-bank, microbiology and specialist access; outpatient phases still require residence near the unit.
The catalog stores $30,000–$80,000 for India, $200,000–$420,000 for typical US self-pay and 6–10 weeks nearby for broad travel planning. These are comparison tokens, not medical acceptance, an outcome forecast or a hospital quotation.
What Is Allogeneic Stem Cell Transplant?
An allogeneic stem cell transplant replaces blood formation with stem cells from another person after conditioning and adds a donor immune effect against selected blood cancers or marrow disorders.
After conditioning, donor peripheral-blood or marrow cells are infused. Immunosuppression supports engraftment and limits graft-versus-host disease while infection surveillance continues.
A donor match alone is not an indication. Uncontrolled infection, refractory disease, major organ impairment or lack of safe long-term follow-up can make transplant unsafe or require a different plan.
When Is Allogeneic Stem Cell Transplant Considered?
It may be considered for selected acute leukaemias, myelodysplastic syndromes, marrow-failure disorders and other high-risk haematological diseases after disease, donor and fitness review.
Work-up includes disease genetics and remission status, high-resolution HLA typing, donor health and infectious screening, organ testing, psychosocial and caregiver assessment and a graft-versus-host disease prevention plan.
How treatment is given, monitored and adapted →
Allogeneic Stem Cell Transplant cost in India
The $30,000–$80,000 value is the stored national planning range for allogeneic stem cell transplant. It may cover only the items expressly named in a hospital letter and does not establish a tariff for any city or provider.
Important drivers include donor type and hla work-up, graft source and procurement, conditioning intensity, gvhd prophylaxis and monitoring, engraftment, infection and complication care. A changed donor, graft, conditioning plan, laboratory work-up or complication can describe a materially different episode.
Do not divide the national range into invented city prices. Compare itemized estimates after record review, and budget travel, caregiver lodging and care after return separately.
This is a transplant-unit episode with protective precautions and rapid ICU, blood-bank, microbiology and specialist access; outpatient phases still require residence near the unit. Return requires stable engraftment, controlled complications, reliable medicines and a receiving transplant clinician. A fixed six-week flight can be medically unrealistic.
Allogeneic Stem Cell Transplant cost breakdown in India
Component prices are rarely published as a public tariff. The lines below describe what typically sits inside a treatment estimate, not a dollar amount for each row.
- Recipient eligibility work-up
- Disease, organ, infection and psychosocial assessment as quoted.
- Quoted donor testing
- Specified HLA, health and infectious testing for the proposed donor.
- Graft collection and processing
- Only the source, collection and laboratory work stated.
- Conditioning, infusion and GVHD prevention
- Named regimens and stated pharmacy allowance.
- Transplant ward and routine surveillance
- Defined nights, counts, drug levels and infection tests.
Planning range or quotation?
The $30,000–$80,000 figure is an indicative planning range. A final hospital quotation is itemised, issued after a consultant reviews your records, and still subject to what is found clinically.
Get a Personalized Cost Estimate
What is usually included in a Allogeneic Stem Cell Transplant package?
No two hospitals draw the line in the same place, so read an estimate for what it excludes as carefully as for what it covers. The pattern below is what listed campuses typically bundle into a hematology estimate for this treatment. Anything not written into your estimate should be assumed to be extra until the hospital confirms otherwise.
Usually included
Usually included
Recipient eligibility work-up
Disease, organ, infection and psychosocial assessment as quoted.
Usually included
Quoted donor testing
Specified HLA, health and infectious testing for the proposed donor.
Usually included
Graft collection and processing
Only the source, collection and laboratory work stated.
Usually included
Conditioning, infusion and GVHD prevention
Named regimens and stated pharmacy allowance.
Usually included
Transplant ward and routine surveillance
Defined nights, counts, drug levels and infection tests.
May be charged separately
May be separate
Unrelated-donor registry procurement
Search, confirmatory typing and international courier fees unless named.
May be separate
Therapy needed to reach remission
Bridging or salvage treatment before conditioning.
May be separate
Major GVHD or infection treatment
Prolonged admission, advanced antimicrobials or second-line immunosuppression.
May be separate
Graft failure or second donation
Repeat collection, boost or second transplant.
May be separate
Long-term immunosuppression and survivorship
Medicines, vaccines and late-effect care after the included interval.
Catalog inclusions listed for this pathway: haematology consultation and records review; named consultant on camera before travel; donor search or collection plan as quoted; inpatient transplant or day-care procedure as indicated; discharge summary to your home haematologist.
What can increase the cost?
These are the drivers that actually move a bill for this procedure, in rough order of how often they do it. Most of them are clinical decisions rather than commercial ones, which is why an honest estimate is written after a records review rather than before it.
- Donor type and HLA work-up
- Related, unrelated and alternative donors require different searches and testing.
- Graft source and procurement
- Peripheral blood, marrow and cord products have different collection logistics.
- Conditioning intensity
- Myeloablative and reduced-intensity regimens differ in pharmacy and toxicity.
- GVHD prophylaxis and monitoring
- Medicines, levels and cellular manipulation must be explicit.
- Engraftment, infection and complication care
- Length of stay and high-cost supportive care vary substantially.
Clinical pathways related to Allogeneic Stem Cell Transplant
A donor match alone is not an indication. Uncontrolled infection, refractory disease, major organ impairment or lack of safe long-term follow-up can make transplant unsafe or require a different plan. The alternatives below are selected clinically, not as price upgrades.
A Transplant hematologist should explain why the proposed pathway fits the diagnosis and what finding could change it.
Swipe to compare treatment approaches →
| Approach | Relative complexity | GAF planning range | Notes |
|---|---|---|---|
| Matched related donor transplant | Selected from diagnosis, fitness and laboratory findings | No separate GAF sheetRelative complexity only | A suitably HLA-matched family donor after independent donor assessment. |
| Matched unrelated donor transplant | Selected from diagnosis, fitness and laboratory findings | No separate GAF sheetRelative complexity only | Registry search and donor procurement add distinct timing and charges. |
| Alternative-donor transplant | Selected from diagnosis, fitness and laboratory findings | No separate GAF sheetRelative complexity only | Haploidentical or cord strategies use different graft and GVHD-prevention assumptions. |
Planning ranges appear only where GAF Healthcare already publishes a cost sheet for that procedure. Other rows describe relative clinical complexity and should not be read as prices.
Risks and safety considerations for Allogeneic Stem Cell Transplant
Risks include graft failure, severe infection, acute or chronic graft-versus-host disease, viral reactivation, organ toxicity, relapse, infertility and treatment-related death.
This is not an exhaustive consent list and does not assign likelihood. Individual risks depend on diagnosis, current blood counts, comorbidity and the actual protocol.
A Transplant hematologist must discuss alternatives, uncertainty and the signs that need urgent assessment; no page can promise success or an uncomplicated recovery.
Allogeneic Stem Cell Transplant cost: India vs other medical tourism destinations
India and United States values use stored GAF ranges. Other country rows are modelled relative private-care bands, not official tariffs or proof that a centre will accept the case.
International comparisons are unreliable unless diagnosis, donor or specimen work, protocol, ward scope, medicines and complication coverage match.
Swipe to compare destinations →
| Country | Approximate cost | Relative cost position | Important cost considerations |
|---|---|---|---|
| India | $30,000–$80,000 | Baseline | GAF catalog planning range. The stored India value is a planning band. A named Hematology specialist must review diagnosis, disease status, donor or graft details and organ fitness before a case-specific quotation. |
| Turkey | $60,500–$99,000Indicative planning estimate* | ≈1.4× India | Private international-care market. Confirm donor work, graft procurement, laboratory testing, ward isolation, complications and outpatient monitoring rather than comparing a headline package. |
| Thailand | $71,500–$121,000Indicative planning estimate* | ≈1.8× India | Private international hospitals. International-patient support does not establish transplant eligibility, donor availability, laboratory scope or a safe handover after return. |
| United Arab Emirates | $121,000–$198,000Indicative planning estimate* | ≈2.9× India | Regional premium private care. Travel may be shorter for some families, while professional fees, graft services, medicines and complication care may remain separate. |
| Singapore | $154,000–$264,000Indicative planning estimate* | ≈3.8× India | High-cost specialist private care. Request an international self-pay estimate tied to the diagnosis, protocol and donor or specimen work rather than a general haematology package. |
| Germany | $137,500–$247,500Indicative planning estimate* | ≈3.5× India | European elective specialist care. Eligibility, donor-registry access, professional billing and post-treatment arrangements vary and must be established before travel. |
| United Kingdom | $121,000–$220,000Indicative planning estimate* | ≈3.1× India | Private self-pay for many visitors. Overseas patients should verify acceptance, donor or laboratory access, quote boundaries and who provides follow-up after discharge. |
| United States | $200,000–$420,000 | ≈5.6× India | Stored self-pay reference. Hospital, specialist, donor, laboratory and pharmacy charges may be billed separately; $200,000–$420,000 is a comparison range, not one bundled quotation. |
*Figures other than India and the United States are modelled planning estimates scaled from the India catalog band, not hospital quotations. All values are planning information. Disease status, donor or graft source, testing, medicines, complications, currency and length of stay can change the final amount; no row predicts safety or outcome.
The point of this table is not that one country is better. Cost level and treatment-market structure are different things. Compare the named hospital, multidisciplinary support, included care and follow-up pathway as carefully as the headline figure.
Which destination is right for you?
Use this only as a reading guide for the table above. It is not a medical recommendation, and it does not rank countries.
Looking for the lowest overall treatment cost?
IndiaLooking for premium private hospital infrastructure?
Singapore / UAELooking for proximity from the Middle East?
UAE / India / TurkeyLooking for established European oncology systems?
Germany / UK
Why do international patients consider India for allogeneic stem cell transplant?
Some international patients compare India for access to a named Transplant hematologist and a self-pay planning range below typical United States figures. Price alone is not a reason to travel.
Clinical acceptance, exact quote scope, emergency capacity, caregiver logistics and continuity after return need direct confirmation.
Urgent illness, uncontrolled infection, lack of a safe caregiver plan or funded appropriate care near home may make international travel unsuitable.
Hematology hospitals for allogeneic stem cell transplant in India
Hospital cards should follow live entity relationships. A general oncology or accreditation label does not establish current transplant beds, apheresis, donor access, haematopathology scope, ICU support or outcomes.
Artemis Hospital
JCI Accredited
NABH Accredited- DHADHA
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Hindi
BLK-Max Super Speciality Hospital
- JCI Accredited
- NABH Accredited
NABL Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Hindi
Medanta - The Medicity
- JCI Accredited
- NABH Accredited
- NABL Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
2 listed doctors for this pathway
Languages listed: English, Hindi
Allogeneic Stem Cell Transplant hospitals in India · Talk to a treatment coordinator
Transplant hematologists for allogeneic stem cell transplant in India
Profiles must be drawn dynamically only when Allogeneic Stem Cell Transplant appears in current procedure relationships. Verify the clinician's Hematology role, responsibility for this pathway, availability and campus. Placement is not a ranking or an experience or outcome claim.
Dr. Divya Doval
Hematology
11+ years Experience
Allogeneic Bone Marrow Transplant · Autologous Bone Marrow Transplant · Bone Marrow Transplant
English, Hindi
Dr. Manisha Jain
Hematology
19+ years Experience
Bone Marrow Transplant · Autologous Bone Marrow Transplant · Allogeneic Bone Marrow Transplant
English, Hindi
Dr. Rahul Naithani
Hematology
15+ years Experience
Bone Marrow Transplant · Allogeneic Bone Marrow Transplant · Autologous Bone Marrow Transplant
English, Hindi
Dr. Tejasvini Vaid
Hematology
12+ years Experience
Acute Leukemia · Lymphoma · Multiple Myeloma
English, Hindi
Allogeneic Stem Cell Transplant doctors in India (4 listed) · Get a personalized cost estimate
Allogeneic Stem Cell Transplant cost by city in India
Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad use $30,000–$80,000 because no verified city tariffs are stored. Their overlays address different airport, commute, climate and caregiver logistics without inventing local prices.
Specialist and hospital cards must resolve from current procedure relationships. This article names no provider and makes no ranking, volume, accreditation or outcome claim.
Swipe to compare Indian cities →
Delhi NCR
$30,000–$80,000
India planning band — not a city quote
Typical stay 6–10 weeks nearby
No verified Delhi NCR-only tariff is stored for allogeneic stem cell transplant. Use $30,000–$80,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
3 hospitals · 4 doctors
Mumbai
$30,000–$80,000
India planning band — not a city quote
Typical stay 6–10 weeks nearby
No verified Mumbai-only tariff is stored for allogeneic stem cell transplant. Use $30,000–$80,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
0 hospitals · consultant match on request
Bengaluru
$30,000–$80,000
India planning band — not a city quote
Typical stay 6–10 weeks nearby
No verified Bengaluru-only tariff is stored for allogeneic stem cell transplant. Use $30,000–$80,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
0 hospitals · consultant match on request
Chennai
$30,000–$80,000
India planning band — not a city quote
Typical stay 6–10 weeks nearby
No verified Chennai-only tariff is stored for allogeneic stem cell transplant. Use $30,000–$80,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
0 hospitals · consultant match on request
Hyderabad
$30,000–$80,000
India planning band — not a city quote
Typical stay 6–10 weeks nearby
No verified Hyderabad-only tariff is stored for allogeneic stem cell transplant. Use $30,000–$80,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
0 hospitals · consultant match on request
Costs vary considerably by hospital, specialist, clinical complexity, insurance, room or day-care category, and what is included in the package.
Choosing a city for allogeneic stem cell transplant
Patients usually pick the treating team first and the city second. The city still affects daily travel, accommodation, companion arrangements and access to follow-up. Here is what genuinely differs between the five cities we list.
What should international patients budget beyond the hematology procedure or treatment?
A complete allogeneic stem cell transplant budget extends beyond $30,000–$80,000. Include record review, tests outside the letter, companion travel, lodging, medicines, complication contingency and follow-up at home.
Travel should follow written clinical acceptance. A visa invitation or directory profile is not medical clearance.
- Disease and fitness review
- Confirm indication, disease control, comorbidity and alternatives.
- Donor selection
- Complete high-resolution HLA typing, donor assessment and graft-source choice.
- Conditioning
- Deliver the disease- and fitness-appropriate preparative regimen.
- Graft infusion
- Infuse the tested donor product and begin the planned GVHD prophylaxis.
- Engraftment and surveillance
- Monitor counts, chimerism, infection, organ effects and acute GVHD.
- Long-term shared care
- Manage immune suppression, chronic GVHD, relapse surveillance and revaccination.
- Treatment episode$30,000–$80,000
- Pre-operative testsOften inside the estimate — confirm
- Hospital stay6–10 weeks nearby typically bundled
- Additional procedures or extended careQuoted separately if advised
- Accommodation for companionVaries by city and length of stay
- Local transportationAirport and daily hospital transfers
- FlightsDepends on origin
- Medical visaFee set by the issuing consulate
Planning estimate — not a hospital quotation.
Get a Personalized Treatment Estimate
What does medical travel for allogeneic stem cell transplant in India involve?
The sequence below is how a records-first pathway normally runs. The order matters: everything before arrival exists so that you are not making decisions in an unfamiliar hospital corridor with a suitcase beside you.
Send complete records
Full pathology, cytogenetics and molecular results; Response marrow and imaging; Complete treatment and infection history; Recipient HLA typing and any donor reports; Organ-function tests and current medicines.
Obtain specialist acceptance
A named Transplant hematologist confirms whether the proposed procedure and travel are reasonable from the available evidence.
Clarify alternatives and uncertainty
A donor match alone is not an indication. Uncontrolled infection, refractory disease, major organ impairment or lack of safe long-term follow-up can make transplant unsafe or require a different plan. Ask what new result could change or cancel the plan.
Compare itemized estimates
Use the same clinical assumptions and compare laboratory, pharmacy, ward, professional and complication terms.
Plan flexible travel
Arrange documents, a capable caregiver when required, refundable travel and accommodation close to the exact campus.
Repeat assessment after arrival
Work-up includes disease genetics and remission status, high-resolution HLA typing, donor health and infectious screening, organ testing, psychosocial and caregiver assessment and a graft-versus-host disease prevention plan.
Complete the planned procedure
After conditioning, donor peripheral-blood or marrow cells are infused. Immunosuppression supports engraftment and limits graft-versus-host disease while infection surveillance continues.
Monitor recovery
Blood-count recovery is only the first milestone. Immune reconstitution, graft-versus-host disease, viral reactivation and immunosuppressant management continue for months. fever, rash, jaundice, persistent diarrhoea, mouth or eye dryness, breathing difficulty, bleeding or inability to take immunosuppressants require prompt review.
Receive discharge records
Carry the procedure summary, laboratory or pathology results, medicine list, emergency contacts and follow-up schedule.
Continue care at home
Serial chimerism, disease assessment, infection surveillance, immunosuppressant levels, GVHD review and later vaccination require a written shared-care plan.
Documents to prepare
- Full pathology, cytogenetics and molecular results
- Response marrow and imaging
- Complete treatment and infection history
- Recipient HLA typing and any donor reports
- Organ-function tests and current medicines
Clinical detail
How the treatment is delivered
After conditioning, donor peripheral-blood or marrow cells are infused. Immunosuppression supports engraftment and limits graft-versus-host disease while infection surveillance continues.
Related approaches include Matched related donor transplant, Matched unrelated donor transplant, Alternative-donor transplant; they are not interchangeable package labels.
This is a transplant-unit episode with protective precautions and rapid ICU, blood-bank, microbiology and specialist access; outpatient phases still require residence near the unit. donor work-up precedes conditioning and infusion, followed by several weeks to engraftment and months of close immune and GVHD monitoring.
Main variations
- Matched related donor transplant
- A suitably HLA-matched family donor after independent donor assessment.
- Matched unrelated donor transplant
- Registry search and donor procurement add distinct timing and charges.
- Alternative-donor transplant
- Haploidentical or cord strategies use different graft and GVHD-prevention assumptions.
Preparation
Work-up includes disease genetics and remission status, high-resolution HLA typing, donor health and infectious screening, organ testing, psychosocial and caregiver assessment and a graft-versus-host disease prevention plan.
The receiving Transplant hematologist should review the complete files, reconcile medicines and explain consent, alternatives and what could postpone or cancel the procedure.
Report fever, active infection, new bleeding, breathing difficulty or a material change in condition promptly; urgent local care should not be delayed for travel.
Hospital stay and recovery
Blood-count recovery is only the first milestone. Immune reconstitution, graft-versus-host disease, viral reactivation and immunosuppressant management continue for months. Serial chimerism, disease assessment, infection surveillance, immunosuppressant levels, GVHD review and later vaccination require a written shared-care plan.
The catalog stay of 6–10 weeks nearby is a planning aid, not a discharge promise. Return requires stable engraftment, controlled complications, reliable medicines and a receiving transplant clinician. A fixed six-week flight can be medically unrealistic.
Risks include graft failure, severe infection, acute or chronic graft-versus-host disease, viral reactivation, organ toxicity, relapse, infertility and treatment-related death.
Seek urgent clinical help for fever, rash, jaundice, persistent diarrhoea, mouth or eye dryness, breathing difficulty, bleeding or inability to take immunosuppressants. Follow the treating team's own emergency thresholds.
How to compare Allogeneic Stem Cell Transplant quotes from Indian hospitals
Print these and work through them on the video call. A house that answers without hedging is telling you something useful about how it will behave when something goes wrong.
- Why is allogeneic stem cell transplant being considered now, and what alternatives were discussed?
- Which diagnosis, pathology or laboratory result drives the recommendation?
- Who is the named Transplant hematologist responsible for the plan?
- At which exact campus will each stage occur?
- What could postpone, change or cancel the procedure after arrival?
- Does the quotation use the exact procedure name and clinical assumptions?
- Which consultations, laboratory tests and imaging are included?
- Which medicines, blood products and supportive care are included?
- How many day-care visits or ward nights are allowed?
- How are intensive care, infection, bleeding and an extended stay billed?
- Which professional, laboratory, pharmacy or donor charges are separate?
- What caregiver presence and nearby accommodation are required?
- What emergency symptoms require return to the unit?
- Who provides care if the patient becomes unwell after returning home?
- When is fitness to fly assessed, and must return travel remain flexible?
- Which donor relationship, HLA match and graft source does the quote assume?
- Are donor assessment, collection and travel included?
- Which conditioning and GVHD-prevention regimens are priced?
- Which chimerism, CMV and other viral tests are included?
- How are graft failure and donor lymphocyte infusion billed?
- Who manages immunosuppression after return?
Frequently asked questions
How much does allogeneic stem cell transplant cost in India?
Allogeneic Stem Cell Transplant is typically planned at $30,000–$80,000. This stored range is not a quote; eligibility, the exact pathway and hospital terms determine the final amount.
What is allogeneic stem cell transplant?
An allogeneic stem cell transplant replaces blood formation with stem cells from another person after conditioning and adds a donor immune effect against selected blood cancers or marrow disorders.
When is allogeneic stem cell transplant considered?
It may be considered for selected acute leukaemias, myelodysplastic syndromes, marrow-failure disorders and other high-risk haematological diseases after disease, donor and fitness review.
Who may not be ready for this procedure?
A donor match alone is not an indication. Uncontrolled infection, refractory disease, major organ impairment or lack of safe long-term follow-up can make transplant unsafe or require a different plan.
What records are needed before acceptance?
Work-up includes disease genetics and remission status, high-resolution HLA typing, donor health and infectious screening, organ testing, psychosocial and caregiver assessment and a graft-versus-host disease prevention plan.
What happens during the procedure?
After conditioning, donor peripheral-blood or marrow cells are infused. Immunosuppression supports engraftment and limits graft-versus-host disease while infection surveillance continues.
How long does allogeneic stem cell transplant take?
donor work-up precedes conditioning and infusion, followed by several weeks to engraftment and months of close immune and GVHD monitoring. The stored 6–10 weeks nearby is only a travel-planning guide.
Is admission required?
This is a transplant-unit episode with protective precautions and rapid ICU, blood-bank, microbiology and specialist access; outpatient phases still require residence near the unit.
What are the important risks?
Risks include graft failure, severe infection, acute or chronic graft-versus-host disease, viral reactivation, organ toxicity, relapse, infertility and treatment-related death.
What can change the hospital estimate?
Key drivers include donor type and hla work-up, graft source and procurement, conditioning intensity, gvhd prophylaxis and monitoring, engraftment, infection and complication care.
When can an international patient fly home?
Return requires stable engraftment, controlled complications, reliable medicines and a receiving transplant clinician. A fixed six-week flight can be medically unrealistic.
What follow-up is needed?
Serial chimerism, disease assessment, infection surveillance, immunosuppressant levels, GVHD review and later vaccination require a written shared-care plan.
Dr. Shabnam Choudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She contributes to the curation and development of medically informative healthcare content, helping ensure that information is structured clearly and presented in a patient-friendly manner.
Content Curator
Dr. Shabnam Choudhary
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru
Dr. Saffiyyah Chaudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She provides medical review of healthcare content to help ensure that clinical information is accurate, understandable, and appropriately presented for patients and their families.
Medically Reviewed By
Dr. Saffiyyah Chaudhary
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru
Related treatment costs
Matched Unrelated Donor Transplant cost in India
$40,000–$95,000 · stay 6–12 weeks nearby
Haploidentical Stem Cell Transplant cost in India
$35,000–$85,000 · stay 6–10 weeks nearby
Bone Marrow Transplantation cost in India
$25,000–$70,000 · stay 4–8 weeks in or near the unit
Cost note
Cost ranges on this page are for preliminary planning and comparison only. The final treatment cost depends on the patient's diagnosis, treatment plan, hospital, doctor, procedure complexity and other clinical factors. A personalized quotation should be obtained before making treatment or travel decisions.
This page is general information about treatment costs and pathways. It is not a diagnosis, a treatment recommendation or a substitute for an individualised medical opinion. Decisions about whether this procedure is appropriate for you belong to a qualified doctor who has reviewed your records.
Last updated 12 September 2026. Cost data is maintained separately from this article and refreshed as listed campuses revise their planning ranges.
Allogeneic Stem Cell Transplant cost sheet · All treatment costs in India · Hematology costs
